Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
We recently hosted Fred Hutch Cancer Center’s Dr. Sara A. Hurvitz for a helpful discussion on the various types of breast assays and tools used to guide treatment decisions and support ongoing surveillance. Dr. Hurvitz is an expert in breast oncology and a leader in clinical and laboratory-based oncology research with extensive experience leading clinical trials in all phases.
Watch the webinar to learn how tests including Oncotype DX, MammaPrint, FoundationOne, and more can help your care team personalize your active treatment plan or play a role in surveillance during survivorship.
